330 related articles for article (PubMed ID: 17761106)
1. Efficacy and its persistence, in children and adults.
Di Rienzo V
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):35-7. PubMed ID: 17761106
[No Abstract] [Full Text] [Related]
2. Oral reactions to sublingual immunotherapy: a bioptic study.
Marcucci F; Sensi L; Incorvaia C; Di Cara G; Moingeon P; Frati F
Allergy; 2007 Dec; 62(12):1475-7. PubMed ID: 17983387
[No Abstract] [Full Text] [Related]
3. [Specific immunotherapy in desensitization of allergic patients. Oral administration instead of injections? (interview by Andrea Warpakowski)].
Grevers G
MMW Fortschr Med; 2003 May; 145(18):18. PubMed ID: 12808815
[No Abstract] [Full Text] [Related]
4. [Sublingual vs subcutaneous immunotherapy].
Olivé Pérez A
Rev Alerg Mex; 2004; 51(1):29-35. PubMed ID: 15119753
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of oromucosal immunotherapy in respiratory allergy.
Brown JL; Frew AJ
Clin Exp Allergy; 2001 Jan; 31(1):8-10. PubMed ID: 11167944
[No Abstract] [Full Text] [Related]
6. LAIS - Posological schedules.
Bruno M
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):33-4. PubMed ID: 17761105
[No Abstract] [Full Text] [Related]
7. [How great is the value of oral hyposensitization in skin test assessed allergy in comparison with parenteral treatment?].
Luger T
Internist (Berl); 1996 May; 37(5):519-20. PubMed ID: 9011553
[No Abstract] [Full Text] [Related]
8. [Apropos of sublingual specific immunotherapy].
Sabbah A
Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
[No Abstract] [Full Text] [Related]
9. Survey on the safety of a no-updosing regimen of sublingual immunotherapy.
Musarra A; Cilia M; Pecora S; Passalacqua G
Eur Ann Allergy Clin Immunol; 2006 Nov; 38(9):313-4. PubMed ID: 17191752
[No Abstract] [Full Text] [Related]
10. LAIS Allergoid.
Mistrello G
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):21-4. PubMed ID: 17761102
[No Abstract] [Full Text] [Related]
11. How to stop the allergy march.
Lopes Dos Santos JM
Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):39-40. PubMed ID: 17761107
[No Abstract] [Full Text] [Related]
12. [Specific immunotherapy. Subcutaneous or sublingual?].
Stiefelhagen P
MMW Fortschr Med; 2008 Jun; 150(24):14, 16. PubMed ID: 18605053
[No Abstract] [Full Text] [Related]
13. [Instead of hyposensitization by injection. Dissolving immunotherapy under the tongue?].
Klein F
MMW Fortschr Med; 2007 Jan; 149(3):16. PubMed ID: 17632861
[No Abstract] [Full Text] [Related]
14. [Accelerated desensitization to lung allergens].
Michel FB; Guerin B; Bousquet J
Tunis Med; 1984; 62(3):201-7. PubMed ID: 6528396
[No Abstract] [Full Text] [Related]
15. Different immunotherapy applications--different mechanisms? SLIT versus SCIT--differences in the mode of action.
Allam JP; Bieber T; Novak N
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():237-40; discussion 240-5. PubMed ID: 20799467
[No Abstract] [Full Text] [Related]
16. Sublingual immunotherapy: from safety to mechanism of action.
Marcucci F; Sensi L; Allocca G; Chiarello F; Palleri P; Ugolini E; Di Rienzo A; Castellani S; Incorvaia C; Di Cara G; Puccinelli P; Frati F
Eur Ann Allergy Clin Immunol; 2007 Mar; 39(3):101-3. PubMed ID: 17465282
[TBL] [Abstract][Full Text] [Related]
17. What do we need to learn to optimize the SLIT alternative?
Serra HM; Alignani DO; Passalacqua G; Canonica GW; Correa SG
Eur Ann Allergy Clin Immunol; 2006 May; 38(5):158-65. PubMed ID: 17058848
[TBL] [Abstract][Full Text] [Related]
18. [Allergen-specific immunotherapy].
Hansen TK; Svendsen UG
Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
[No Abstract] [Full Text] [Related]
19. [Allergy vaccination with only 4 injections per year].
Krankenpfl J; 2005; 43(7-10):261-2. PubMed ID: 16515332
[No Abstract] [Full Text] [Related]
20. [Practical problems in specific hyposensitization].
Oehling A
Med Klin; 1972 Jul; 67(29):983-8. PubMed ID: 5051382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
